Effect of Achyranthes bidentata Blume extract on carrageenan-induced chronic prostatitis in rats
Purpose: To investigate the effect of Achyranthes bidentata Blume. Extract (ABBE) on carrageenaninduced chronic prostatitis in rats.
Methods: Experimental chronic non-bacterial prostatitis (CNP) was induced in rats by 1 % carrageenan (0.1 mL). Prostate index (PI) and prostate specific antigen (PSA) were determined after 3 weeks of adiministration. Relative inflammatory factors, viz, tumor necrosis factor-α (TNF-α), interleukin1β (IL-1β), cyclooxygenase-2 (COX-2), prostaglandin E2 (PEG2), transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) in the prostate tissues of all group rats were measured.
Results: In CNP model, ABBE decreased PI and PSA compared with untreated control group (p < 0.01). Morphometric analysis showed a significant reduction in chronic inflammatory cell infiltrates and interstitial fibrosis compared to control group. Reduced values of TNF-α, IL-1β, COX-2, PEG2 were observed in ABBE-treated groups compared with model group respectively (p < 0.01). Moreover, the levels of TGF-β1 and CTGF in ABBE-treated groups were significantly lower, and in addition, there was alleviation of the inflammatory state of the prostate gland (p < 0.01).
Conclusion: ABBE showed antichronic non-bacterial prostatitis effect by multiple ways in rats, thus indicating its potential suitability for the treatment of chronic prostatitis.
Keywords: Achyranthes bidentata Blume., Chronic prostatitis, Inflammatory cell
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.